Travel Health Xpert Clinical alert "Travel Health Xpert"
Online version
Travel Health Xpert
Latest science about Travel Health
From Peer-Reviewed Journals in Full-text version - Tuesday May 13, 2025
Welcome     ,
Find hereafter the latest scientific and medical publications focused on your area of expertise.
CISTM 2025
Expert Opinion
Prof. D.H. HAMER Hepatitis A - easily preventable with widespread risk even in countries with low endemicity
 Pr David HAMER | Reading time: 1 min.
While the risk of hepatitis A remains high in many low- and middle-income countries, transmission of hepatitis A virus continues at in many European countries and the United States. Given the availability...
 Read article
 
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review
Hepatitis A Journal of Viral Hepatitis 2023; 30(6): 497-511 | Reading time: 6 min.
Hepatitis A (HA) is a vaccine‐preventable liver disease caused by a single‐stranded ribonucleic acid virus (HAV). Infection may result in severe outcomes, especially at increasing ages and...
 Read article
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies
Hepatitis A The Journal of infectious diseases 2024; 230(1): 5 | Reading time: 4 min.
Hepatitis A (HepA) vaccines are recommended for United States (US) adults at risk of HepA. Ongoing US HepA outbreaks since 2016 have primarily spread person-to-person, especially among at-risk groups....
 Read article
Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014.
Hepatitis A International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 Feb | Reading time: NaN min.
We analysed Hepatitis A (HepA) notifications and hospitalisations in Italy, Netherlands, Norway, Spain and Sweden for available periods between 1995 and 2014 to investigate whether decreasing HepA incidence...
 Read article |  Free Full-text
Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020.
Hepatitis A MMWR. Morbidity and mortality weekly report 2022 Sep; 71(39): 1229-1234 | Reading time: NaN min.
Hepatitis A is a vaccine-preventable disease typically acquired through fecal-oral transmission. Hepatitis A virus (HAV) infection rates in the United States declined approximately 97% during 1995-2015...
 Read article |  Free Full-text
Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008-2020.
Hepatitis A Journal of travel medicine 2022 Mar; 29(2) | Reading time: NaN min.
 Read article |  Free Full-text
More articles about Travel Health
Vaccines Beat 2025
Filters:  Editorial | Experts Opinions | Congress Highlights
Chikungunya | Editorial (FR) | Cholera | Dengue Fever | Diphteria | Hepatitis A | Hepatitis B | Japanese Encephalitis | Lyme Disease | Malaria | Travellers Diarrhea | Typhoid | Yellow Fever | Zika | Tick Borne Encephalitis (TBE) | Rabies
The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.
GNM Healthcare
Copyright 2025 © GNM Healthcare Group Companies USA, Inc.
Edit my profile | Refer a Colleague | Delete my data
By requesting access to the "Travel Health Xpert" service, I agree that GNM Healthcare Group Companies USA, Inc. may use the data acquired during my access request to provide me with fortnightly information related to its services in accordance with the Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to dpo@gnmhealthcare.com. You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.